Press Room - Sanofi US News

Menu

Media Room Menu

Month Year

Month Year

Dec 8, 2006

Rimonabant update in the United States
Dec 5, 2006

New data shows Rimonabant benefited patients with type 2 diabetes by improving blood sugar control, reducing weight and acting on other cardiometabolic risk factors

First Rimonabant Trial with HbA1c as a Primary Endpoint
Nov 27, 2006

Sanofi Pasteur Completes Shipment of 50 Million Doses of Influenza Vaccine

Sanofi pasteur able to produce additional vaccine to meet customer demand
Nov 20, 2006

Sanofi Pasteur Signs Contract with U.S. Government for Stockpile of New Type of H5N1 Pre-Pandemic Vaccine

New pre-pandemic vaccine will provide additional level of preparedness
Oct 31, 2006

First 9th months of 2006: Sales growth of 2.6% on a comparable basis - Adjusted EPS growth of 15.0%, or 7.5% excluding selected items

Sales Growth of 2.6% on a Comparable Basis(1)

Show per page

Print
Email page
RSS

You are about to leave www.sanofi.us

If you wish to continue to this external website, click Proceed. It is provided for information only. Sanofi assumes no responsibility for the information presented on this website.